Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors

被引：0
|
作者：
Tailor, Dhanir
Garcia-Marques, Fernando Jose
Bermudez, Abel
Li, Wenqi
Dheeraj, Arpit
Pitteri, Sharon J.
Malhotra, Sanjay V.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5935
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [22] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Heeke, Arielle L.
    Tan, Antoinette R.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (02) : 537 - 547
  • [23] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Arielle L. Heeke
    Antoinette R. Tan
    Cancer and Metastasis Reviews, 2021, 40 : 537 - 547
  • [24] Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor
    Song, Dandan
    He, Huan
    Sinha, Indranil
    Hases, Linnea
    Yan, Feifei
    Archer, Amena
    Haldosen, Lars-Arne
    Zhao, Chunyan
    Williams, Cecilia
    CANCER LETTERS, 2021, 506 : 23 - 34
  • [25] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [26] BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (04) : 343 - 343
  • [27] PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Geenen, Jill J. J.
    Linn, Sabine C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CLINICAL PHARMACOKINETICS, 2018, 57 (04) : 427 - 437
  • [28] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Zhang, Xia
    Bai, Weijun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) : 655 - 659
  • [29] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence
    Farshbafnadi, Melina
    Khoshbin, Amin Pastaki
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
12345